Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pepsin and autoimmune disease mouse.

H Ohnishi

    Life Sciences
    |October 24, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Pepsin treatment improved survival and kidney health in MRL/1 mice with autoimmune glomerulonephritis. This immune complex nephritis therapy reduced harmful antibodies and normalized immune cell function.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Bronchus-associated lymphoid tissue (BALT) lymphoma and autoimmune disease.

    QJM : monthly journal of the Association of Physicians·2022
    Same author

    Calcinosis and acro-osteolysis in systemic sclerosis.

    QJM : monthly journal of the Association of Physicians·2021
    Same author

    Involvement of autophagy in the maintenance of rat intervertebral disc homeostasis: an in-vitro and in-vivo RNA interference study of Atg5.

    Osteoarthritis and cartilage·2021
    Same author

    Search for η^{'} Bound Nuclei in the ^{12}C(γ,p) Reaction with Simultaneous Detection of Decay Products.

    Physical review letters·2020
    Same author

    Beam Energy and Centrality Dependence of Direct-Photon Emission from Ultrarelativistic Heavy-Ion Collisions.

    Physical review letters·2019
    Same author

    Surfactant protein D inhibits activation of non-small cell lung cancer-associated mutant EGFR and affects clinical outcomes of patients.

    Oncogene·2017
    Same journal

    Corrigendum to "Adipose stem cells-derived microvesicles and chicken egg-derived exosomes attenuate cardiac ischemia/reperfusion injury through AKT/ERK/Nrf2/HO-1 axis to inhibit apoptosis and inflammation and restore autophagy" [Life Sci. 395 (2026) 124364].

    Life sciences·2026
    Same journal

    MAGED1 stabilizes NEUROD1 to promote Per3 expression in the pineal gland.

    Life sciences·2026
    Same journal

    TNF-centered network pharmacology and molecular modeling of selected Andrographis paniculata compounds in hypertension.

    Life sciences·2026
    Same journal

    Retraction notice to "Beneficial effect of Calculus Bovis Sativus on 17α-ethynylestradiol-induced cholestasis in the rat" [Life Sci. 113 (2014) 22-30].

    Life sciences·2026
    Same journal

    Soluble PD-1 drives renal fibrosis in CKD by disrupting immune homeostasis: Therapeutic mitigation via a targeted sPD-1 sequestration strategy.

    Life sciences·2026
    Same journal

    METTL1 promotes hepatic steatosis by mediating m<sup>7</sup>G modification of ALOX15B mRNA.

    Life sciences·2026
    See all related articles

    Area of Science:

    • Immunology
    • Nephrology
    • Pharmacology

    Background:

    • Autoimmune glomerulonephritis is a severe kidney disease characterized by immune complex deposition.
    • MRL/1 mice are a model for studying lupus nephritis, a type of immune complex nephritis.
    • Current treatments for lupus nephritis have limitations, necessitating novel therapeutic approaches.

    Purpose of the Study:

    • To investigate the therapeutic effects of pepsin on autoimmune glomerulonephritis in MRL/1 mice.
    • To evaluate pepsin's impact on survival, kidney pathology, and immune markers.
    • To explore pepsin's potential as a treatment for immune complex-mediated kidney disease.

    Main Methods:

    • Intravenous administration of pepsin to MRL/1 mice.
    • Monitoring of survival rates and urinary protein excretion.

    Related Experiment Videos

  • Assessment of kidney histopathology.
  • Measurement of serum immune complex and anti-double-stranded DNA (anti-dsDNA) antibody levels.
  • Analysis of lymphocyte subsets and functions.

    • Main Results:

    • Pepsin administration significantly improved survival rates in MRL/1 mice.
    • Pepsin suppressed proteinuria and ameliorated kidney histopathological damage.
    • Serum levels of immune complexes and anti-dsDNA antibodies were reduced by pepsin treatment.
    • Pepsin normalized abnormalities in lymphocyte subsets and immune cell functions.

    Conclusions:

    • Pepsin demonstrates significant therapeutic effects against autoimmune glomerulonephritis in MRL/1 mice.
    • Pepsin's ability to modulate immune responses suggests a role in preventing and treating immune complex nephritis.
    • Further research into pepsin as a potential treatment for human kidney diseases is warranted.